MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As reported in the Wall Street Journal Health Blog ... Microsoft continues its push into health care, inking a deal with Merck to acquire certain assets of Rosetta Biosoftware, a unit of Rosetta Inpharmatics, a company near Seattle that Merck acquired in 2001. Rosetta makes use of powerful computers and gene analysis to figure out which compounds might make the best drugs...

Microsoft plans to incorporate the genetic and genomic data-management software into Microsoft Amalga Life Sciences, which helps research organizations cobble together data from a lot of different systems, both internal and external. Amalga is part of a push by Microsoft, whose other offerings include patient health-records holder HealthVault, to become a bigger player in health care...

Read an at: http://blogs.wsj.com/health/2009/06/02/microsoft-buys-genetic-data-...

ENJOY!

CC

Views: 2

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service